Table 1. Laboratory evaluation . 2-y... | American Society of Hematology

Table 1.

Laboratory evaluation

	2-y preinhibitor	2-y preinhibitor, 1 h post-VWF infusion	Postinhibitor day 0, 5 min post-VWF infusion	Postinhibitor day 7, preinfusion	Postinhibitor day 7, 30 min post-VWF infusion
FVIII activity, %	3	47	0.4	2	0.64
Ristocetin cofactor activity, %	<10	37	39	<10	<10
VWF antigen, %	<15	101	64	<15	<15
FVIII inhibitor, Bethesda units			13.3	17.8	17.5

	2-y preinhibitor	2-y preinhibitor, 1 h post-VWF infusion	Postinhibitor day 0, 5 min post-VWF infusion	Postinhibitor day 7, preinfusion	Postinhibitor day 7, 30 min post-VWF infusion
FVIII activity, %	3	47	0.4	2	0.64
Ristocetin cofactor activity, %	<10	37	39	<10	<10
VWF antigen, %	<15	101	64	<15	<15
FVIII inhibitor, Bethesda units			13.3	17.8	17.5